Search

Your search keyword '"Miyakoda, Keiko"' showing total 6 results
Start Over Author "Miyakoda, Keiko" Publisher wiley
6 results on '"Miyakoda, Keiko"'

1. Risk of major congenital malformations associated with first‐trimester exposure to propulsives: A health administrative database study in Japan

Author

Ishikawa, Tomofumi, primary, Obara, Taku, additional, Akazawa, Manabu, additional, Noda, Aoi, additional, Oyanagi, Gen, additional, Morishita, Kei, additional, Miyakoda, Keiko, additional, Nishigori, Hidekazu, additional, Kawame, Hiroshi, additional, Yaegashi, Nobuo, additional, Kuriyama, Shinichi, additional, and Mano, Nariyasu, additional

Published
2021
Full Text
View/download PDF

2. Folic acid prescribed to prenatal and postpartum women who are also prescribed antiepileptic drugs in Japan: Data from a health administrative database

Author

Ishikawa, Tomofumi, primary, Obara, Taku, additional, Jin, Kazutaka, additional, Nishigori, Hidekazu, additional, Miyakoda, Keiko, additional, Akazawa, Manabu, additional, Nakasato, Nobukazu, additional, Yaegashi, Nobuo, additional, Kuriyama, Shinichi, additional, and Mano, Nariyasu, additional

Published
2020
Full Text
View/download PDF

3. Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database

Author

Ishikawa, Tomofumi, primary, Obara, Taku, additional, Jin, Kazutaka, additional, Nishigori, Hidekazu, additional, Miyakoda, Keiko, additional, Suzuka, Masato, additional, Ikeda-Sakai, Yasuko, additional, Akazawa, Manabu, additional, Nakasato, Nobukazu, additional, Yaegashi, Nobuo, additional, Kuriyama, Shinichi, additional, and Mano, Nariyasu, additional

Published
2019
Full Text
View/download PDF

4. Antihypertensives prescribed for pregnant women in Japan: Prevalence and timing determined from a database of health insurance claims

Author

Ishikawa, Tomofumi, primary, Obara, Taku, additional, Nishigori, Hidekazu, additional, Miyakoda, Keiko, additional, Ishikuro, Mami, additional, Metoki, Hirohito, additional, Ohkubo, Takayoshi, additional, Sugawara, Junichi, additional, Yaegashi, Nobuo, additional, Akazawa, Manabu, additional, Kuriyama, Shinichi, additional, and Mano, Nariyasu, additional

Published
2018
Full Text
View/download PDF

6. Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan.

Author

Ishikawa T, Obara T, Akazawa M, Noda A, Oyanagi G, Morishita K, Miyakoda K, Nishigori H, Kawame H, Yaegashi N, Kuriyama S, and Mano N

Subjects
Databases, Factual, Female, Gastrointestinal Agents, Humans, Infant, Japan epidemiology, Pregnancy, Pregnancy Trimester, First, Abnormalities, Drug-Induced, Domperidone adverse effects
Abstract

Purpose: To evaluate the risk of major congenital malformations (MCMs) associated with first-trimester exposure to propulsives with a special focus on domperidone using a large administrative database in Japan., Methods: A large claims database was used from January 2005 to August 2016. The dates of pregnancy onset and delivery were estimated using the developed algorithms. MCMs were defined according to the International Classification of Diseases, 10th revision codes. We compared the infants' risk of overall MCMs between women with or without first-trimester prescriptions of propulsives and estimated the odds ratios (ORs) with unadjusted and adjusted analyses. We also compared the risk of overall MCMs between women with domperidone prescriptions and those with other propulsive prescriptions during the first trimester., Results: Among 38 270 women, propulsives were prescribed to 3197 women (8.4%) in the first trimester, including domperidone to 371 women (1.0%). Propulsive prescriptions in the first trimester were not significantly associated with an increased risk of overall MCMs (adjusted OR [aOR] 1.030, 95% confidence interval [CI] 0.843-1.257). Compared to the prescription of other propulsives in the first trimester, the prescription of domperidone in the first trimester was not associated with an increased risk of overall MCMs (aOR 0.724, 95% CI 0.363-1.447)., Conclusions: The first-trimester prescription of propulsives, including domperidone, was not associated with an increased risk of overall MCMs., (© 2021 John Wiley & Sons Ltd.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results